Listed below are three shares added to the Zacks Rank #5 (Sturdy Promote) Record as we speak:
Atossa Therapeutics, Inc. ATOS is a clinical-stage biopharmaceutical firm. The Zacks Consensus Estimate for its present yr earnings has been revised 4% downward during the last 60 days.
Bridgeline Digital, Inc. BLIN is a advertising know-how firm. The Zacks Consensus Estimate for its present yr earnings has been revised 12% downward during the last 60 days.
Cantaloupe, Inc. CTLP is a digital fee and software program companies firm. The Zacks Consensus Estimate for its present yr earnings has been revised 6.7% downward during the last 60 days.
View all the Zacks Rank #5 Record.
Past Nvidia: AI’s Second Wave Is Right here
The AI revolution has already minted millionaires. However the shares everybody is aware of about aren’t more likely to maintain delivering the largest earnings. Little-known AI corporations tackling the world’s largest issues could also be extra profitable within the coming months and years.
See “2nd Wave” AI shares now >>
Bridgeline Digital, Inc. (BLIN) : Free Inventory Evaluation Report
Atossa Genetics Inc. (ATOS) : Free Inventory Evaluation Report
Cantaloupe, Inc. (CTLP) : Free Inventory Evaluation Report
This text initially revealed on Zacks Funding Analysis (zacks.com).
The views and opinions expressed herein are the views and opinions of the creator and don’t essentially mirror these of Nasdaq, Inc.
